Bone Biologics Study Shows Bone Formation in Spine Model
Preclinical animal study results indicate that Bone Biologics' rhNELL-1 growth factor effectively promoted bone formation in a spine model. ...
Preclinical animal study results indicate that Bone Biologics' rhNELL-1 growth factor effectively promoted bone formation in a spine model. ...
Carmell Therapeutics announced FDA clearance of an Investigational New Drug application for the company’s Bone Healing Accelerant and enrollment in...
Seikagaku and Ono Pharmaceutical submitted a new drug application for manufacturing and marketing approval for ONO-5704/SI-613 injectable in Japan for the treatment of...
OrthoPediatrics commenced U.S. launch of QuickPackâ„¢ synthetic bone graft substitute....
Bioventus secured preferred access to DUROLANE, GELSYN-3 and SUPARTZ FX to treat knee OA pain for certain Blue Cross Blue Shield of Michigan patients. ...
In2Bones commenced global launch of the AlloAid BioNailâ„¢ engineered allograft implant for reconstructive surgery of the hand and foot....
Hensler Surgical filed a lawsuit against Tobra Medical, alleging patent infringement relative to the Tobra Medical Bone Basket....
Anika Therapeutics is commencing full U.S. commercial launch of TACTOSET surgically-delivered therapy for bone repair procedures....
FDA approved Cerapedics' Premarket Approval supplement for i-FACTOR® Peptide Enhanced Bone Graft for use in ACDF to treat degenerative cervical disc disease....
Personalized Stem Cells treated the first patients in an FDA-approved clinical trial for stem cell treatment of knee osteoarthritis....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.